A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

CD4-IgG

Trial Locations (7)

10032

Columbia Univ Babies' Hosp, New York

11021

North Shore Univ Hosp, Great Neck

33136

Univ of Miami School of Medicine, Miami

60612

Cook County Hosp, Chicago

70112

Tulane Univ Med School, New Orleans

77030

Texas Children's Hosp / Baylor Univ, Houston

92103

UCSD Treatment Ctr, San Diego

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH